LYNCH DANIEL sold 36.5% of their position (47.60K shares) of SPRINGWORKS THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.87M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/24/2025ACC: 0001104659-25-016614
Director
Since Sep 2019
-47.60K
Net shares
Net seller
$2.87M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
47.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−44.02K
Price / share
$60.14
Trade value
$2.65M
% of position
33.7%
2/20/2025
130.54K→86.53K
Common Stock
Direct
Shares
−3.58K
Price / share
$61.24
Trade value
$219.35K
% of position
4.1%
2/20/2025
86.53K→82.94K
Total
Net shares
−47.60K
Net value
-$2.87M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2025 | S · Sale | −44.02K | $60.14 | $2.65M | 33.7% | 130.54K | 86.53K |
| Common Stock Direct | 2/20/2025 | S · Sale | −3.58K | $61.24 | $219.35K | 4.1% | 86.53K | 82.94K |
| Total | −47.60K | -$2.87M | ||||||
Derivative Transactions0
No derivative transactions reported